Stroke
Conditions
Keywords
Stroke, Thrombolysis, Rural CT
Brief summary
To counteract long term sequelae from stroke, ultrarapid diagnosis and treatment, high quality multidiciplinary in-hospital care and optimal long term rehabilitation is required. In this study, the investigators are moving the essential first diagnosis and treatment out into the community close to where the patient live, thus shortening the all important time from debut of symptoms to thrombolytic treatment improving the prognosis of stroke patients.
Detailed description
Stroke is an acute, potentially mutilating disease. To counteract long term sequelae three factors are essential: Ultrarapid diagnosis and treatment, high quality multidiciplinary in-hospital care and optimal long term rehabilitation. Initial diagnosis and treatment has up to now been completed within the hospital domain. This study will change that: moving the essential first diagnosis and treatment out into the community close to where the patient lives thus shortening the all important time from debut of symptoms to thrombolytic treatment. We will operate a local computer tomography (CT) service in the hands of community based non-specialized health care personnel (MD and nurse) acting under direct telemetric guidance from on call hospital specialists. Thus, the investigators will show that by combining current technological advances in real time video communication with an acutely well functioning cooperation between the community and hospital health service personnel the prognosis of stroke patients is improved.
Interventions
DIAGNOSTIC_TESTRural CT scanning
Rural computer tomography for acute stroke
Sponsors
Extrastiftelsen
Vestre Viken Hospital Trust
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Patients over 18 years being investigated by CT within 24 hours for acute symptoms of stroke. 2. Fullfilling criteria for the diagnosis acute stroke as described by the Norwegian stroke registry. 3. Giving informed consent.
Exclusion criteria
1. Symptoms not due to ischaemic or haemorrhagic stroke as adjudicated at discharge. 2. Not able to cooperate to 3 months follow up. 3. Not giving informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Thrombolytic treatment | 3 months | The proportion of patients with ischaemic stroke receiving thrombolytic treatment in percent. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Ictus to needle time | 3 months | Time from onset of stroke symptoms (Ictus) to thrombolytic treatment (Needle). |
| Functional status | 3 months | Modified Rankin Scale (mRS score 0-6). Good outcome 0-2 |
| Cognitive status | 3 months | Montreal Cognitive Assessment (MoCA score 0-30). Good outcome 26-30 |
| Depression | 3 months | Geriatric depression scale (GDS score 0-30). Good outcome 0-10 |
Countries
Norway
Outcome results
None listed